Composition

Each 1 mL of solution contains 6 mg of liraglutide*. One pre-filled pen contains 18 mg liraglutide in 3 mL. *human glucagon-like peptide-1 (GLP-1) analogue produced by recombinant DNA technology in Saccharomyces cerevisiae Excipients: Disodium Phosphate Dihydrate, Propylene Glycol, Phenol, Hydrochloric Acid (for PH Adjustment), Sodium Hydroxide (for PH Adjustment), Water for Injections  

ATC Code/ATCvet Code

A10BJ02  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

3 mL x 3's (in Pre-filled pens)  

Product Description

Solution for injection Clear and colorless or almost colorless, isotonic solution; pH=8.15 10/30/2024 19:15:57 Saxenda 6 mg/ml solution for injection in pre-filled pen 1 ml of solution contains 6 mg of liraglutide*. One pre-filled pen contains 18 mg liraglutide in 3 ml. A6-100004 Solution for injection intravenously or intramuscularly. 1 ml of solution contains 6 mg of Liraglutide One pre-filled pen contains 18 mg liraglutide in 3 ml. 3x3ml POM Novo Nordisk Pharma Ltd Nigeria 4th Floor GIL Group Buidling, 10, Gbolahan Lawal Close, Off Ashabi Cole Street, Alausa CBD, Ikeja, Lagos-Nigeria Novo Nordisk A/S Novo Nordisk A/S Novo Allé DK-2880 Bagsværd Denmark Denmark 09/10/2020 08/10/2025 No A10BJ02

Manufacturer Name

Novo Nordisk A/S

Manufacturer Country

DENMARK  

Approval Date

2020-10-09  

Expiry Date

2025-10-08